The crisis of antibiotic resistance is making the discovery and development of new antibiotics crucial, and companies are teaming up to tackle the growing challenge. But managing collaborative drug discovery data is tough, requiring many small biotechs to rethink how they share and manage their data for antimicrobial development.
Andrej Trauner, Project Manager at Swiss biotech BioVersys explains how his company leverages cutting-edge informatics systems to speed up antimicrobial research. See link to full article on Labiotech.
